Analysis
TJX Companies successfully mitigated the impact of the U.S. tariffs introduced in April 2025 (commonly referred to as the Liberation Day or reciprocal tariffs) throughout its fiscal year 2026. The company identified the second quarter of fiscal 2026 as the most impacted period, primarily due to incremental costs on directly sourced merchandise that were already committed when the additional tariffs were announced in March and April 2025. Despite this headwind, TJX reported that its merchandise margin remained flat in the second quarter and increased in subsequent quarters as its mitigation strategies took full effect.
The company's primary mitigation strategy leverages its opportunistic buying model and flexible supply chain. By maintaining high liquidity and sourcing from a global network of over 21,000 vendors, TJX's buyers were able to negotiate more favorable prices in a marketplace characterized by high inventory availability and vendor "uneasiness" regarding trade policy. Management noted that availability was "off the charts" in many categories, allowing them to buy better and offset the gross headwind of increased duties. Furthermore, TJX selectively adjusted its retail "tickets" (prices) in response to higher prices at traditional retailers, successfully maintaining its target value gap. This pricing strategy was cited as roughly 95% successful across categories, with strong consumer value perception scores confirming that customers accepted the adjustments.
In February 2026, the U.S. Supreme Court invalidated the tariffs originally imposed under the International Emergency Economic Powers Act (IEEPA), which had formed the basis of the April 2025 duties. While this ruling potentially allows TJX to recover previously paid tariff amounts, a subsequent executive order immediately imposed a "new global tariff" to replace the invalidated ones. As of today, TJX has maintained its guidance for fiscal 2027, assuming it can continue to offset any incremental tariff pressure through its established sourcing, pricing, and operational efficiency initiatives.
Financial performance during the initial tariff period was robust, with the company beating its original fiscal 2026 guidance across all major metrics. Net sales surpassed $60B for the first time, and consolidated comparable sales grew 5%, indicating no observed demand destruction or negative revenue impact from the tariff-related pricing actions. Adjusted pre-tax profit margin expanded to 11.7% for the full year, a 20 basis point increase over fiscal 2025, demonstrating that the company was able to more than offset the "significant incremental pressures" it had initially anticipated.
($B, except per share data)
| Metric | FY26 Actual | FY26 Initial Guide | FY25 Actual |
|---|---|---|---|
| Net Sales | $60.4 | $58.1 – $58.6 | $56.4 |
| Comp Sales Growth | 5% | 2.5% | 4% |
| Pre-Tax Profit Margin | 12.1% | 11.3% – 11.4% | 11.5% |
| Diluted EPS | $4.87 | $4.34 – $4.43 | $4.26 |
Source: Annual Report FY-2026, 1Q-2026 Transcript, Marvin Labs
Sources
We're confident in our ability to navigate the current tariff and macro environment in the short term. Importantly, our vision for long-term growth, profitability, and market share opportunities remains the same.
Importantly, we are very pleased with our mitigation strategies, which allowed us to offset all the tariff pressure we saw in the third quarter.
Our full year guidance assumes that we will be able to offset the tariff pressure on our business this year. We're making an assumption that the current level of tariffs on imports into the U.S. will stay in place for the remainder of the year.